Pulmonary toxicity of antineoplastic therapy.
- 1 October 1992
- journal article
- review article
- Vol. 19 (5) , 508-20
Abstract
Pulmonary toxicity is often encountered in patients receiving antineoplastic therapy. It may produce a wide variety of clinicopathologic syndromes. As new agents are introduced and their adverse effects recognized, clinicians should be ever vigilant about the possibility of pulmonary toxicity.This publication has 0 references indexed in Scilit: